Showing 961 - 980 results of 18,229 for search 'significantly ((((greater decrease) OR (((nn decrease) OR (a decrease))))) OR (linear decrease))', query time: 0.77s Refine Results
  1. 961

    Baseline characteristics of overall population. by Krystal Hunter (6820052)

    Published 2025
    “…For every increase in BMI, there was a decrease in the probability of PTB (OR = 0.923, 95% CI 0.915–0.931, P < 0.001). …”
  2. 962

    Diagram of study population. by Krystal Hunter (6820052)

    Published 2025
    “…For every increase in BMI, there was a decrease in the probability of PTB (OR = 0.923, 95% CI 0.915–0.931, P < 0.001). …”
  3. 963

    Results of the LMM analysis for IOP change. by Sayaka Kimura-Uchida (22793666)

    Published 2025
    “…Preoperative factors, particularly medication use, influenced outcomes, indicating that BB or ROCK inhibitors were associated with a greater reduction in the need for postoperative antiglaucoma medications.…”
  4. 964

    Results of the LMM analysis for GMS change. by Sayaka Kimura-Uchida (22793666)

    Published 2025
    “…Preoperative factors, particularly medication use, influenced outcomes, indicating that BB or ROCK inhibitors were associated with a greater reduction in the need for postoperative antiglaucoma medications.…”
  5. 965

    Table 2_Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC.docx by Yulin Zhang (510822)

    Published 2025
    “…Knockdown of HNRNPC in the HNSCC cell lines HSC-3 and CAL-27 resulted in a significant decrease in proliferation, invasion, and malignant transformation abilities. …”
  6. 966

    Table 1_Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC.docx by Yulin Zhang (510822)

    Published 2025
    “…Knockdown of HNRNPC in the HNSCC cell lines HSC-3 and CAL-27 resulted in a significant decrease in proliferation, invasion, and malignant transformation abilities. …”
  7. 967
  8. 968
  9. 969
  10. 970
  11. 971
  12. 972

    Data Sheet 1_Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greate... by Ayman Alhejazi (21092054)

    Published 2025
    “…Background<p>Multiple myeloma (MM) is a plasma cell malignancy with significant unmet medical needs, particularly in the treatment of relapsed and refractory disease. …”
  13. 973
  14. 974
  15. 975
  16. 976
  17. 977
  18. 978
  19. 979
  20. 980